Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

A medication used to treat narcolepsy and attention deficit hyperactivity (ADHD) in adults and children is being recalled by the manufacturer because some of the tablets exceed weight requirements, which could make them super-potent and could pose a risk to consumers who take them.

The recall, announced by the Food and Drug Administration (FDA) includes Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate (mixed salts of a single entity amphetamine product) 20 mg tablets, 100-count bottles, lot number 311756. The recalled lot, made by Barr Laboratories, Inc., was distributed between June 6, 2009 and June 16, 2009.

Read the rest of this entry »

The Food and Drug Administration (FDA) has issued a Safety Communication about an ongoing review of stimulant medication used in children with attention-deficit hyperactivity disorder (ADHD) because of reports of sudden cardiac death in healthy children. The events are part of a study published in the American Journal of Psychiatry. Because of the study’s limitations, the FDA urges parents not to stop a child’s stimulant medication based on the study and to discuss concerns about the use of these medications with the health care professional who prescribed the medications.

Read the rest of this entry »